Molecular changes associated with breast cancer progression were chara
cterized using the MCF-10F cell series. MCF-10F was established from f
ibrous mastectomy tissue of a patient without detectable cancer. In vi
tro treatment of MCF-10F cells with benzo(a)pyrene resulted in a trans
formed subclone MCF-10F-BP1 (BP1), Transfection of clone BP1 with T24-
Hras resulted in the tumorigenic line MCF-10F-BP1 -Tras (BP1-Tras), Us
ing flow cytometry, the expression of HLA I, ERBB-2 and MUC-1 was foun
d to be comparable in 'normal' MCF-10F, transformed BP1 and tumorigeni
c BP1-Tras cells. Glycosylated mucin is elevated in BP1 but reduced in
BP1-Tras cells, Using mRNA differential display analysis, cDNA profil
es of the 'normal', transformed and tumorigenic cell lines were striki
ngly similar, yet distinct and elevated expression of several common c
DNA fragments was detected in BP1 and BP1-Tras when compared with MCF-
10F cells. These fragments were cloned and sequenced. The sequences of
clones T1-360 and C4-310 are homologous to two reported EST cDNA clon
es from human fetal tissue and were further characterized. Elevated ex
pression of the genes corresponding to clones T1-360 and C4-310 was ve
rified using Northern blotting. High-level expression of these genes w
as also detected in the breast cancer cell line MCF-7 that was derived
from the pleural effusion of a patient with advanced breast cancer, T
herefore, specific molecular changes associated with breast cancer dev
elopment were identified and may be indicators of neoplastic progressi
on.